Survival TRaining for ENhancing Total Health (STRENGTH)
NCT00068458 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 39
Last updated 2017-12-19
Summary
RATIONALE: A home-based exercise and/or diet program may improve the quality of life of breast cancer patients by preventing an increase in body fat and weight and a loss of lean body tissue.
PURPOSE: This randomized phase II trial is studying the effectiveness of three home-based diet and/or exercise programs in preventing weight gain and loss of muscle tissue in women who are receiving chemotherapy for stage I, stage II, or stage IIIA breast cancer.
Conditions
- Breast Cancer
- Depression
- Weight Changes
Interventions
- DIETARY_SUPPLEMENT
-
Calcium-Rich Diet
1,200 - 2,500 mg/day. 6 month intervention
- OTHER
-
Arm 2: Exercise + Calcium-Rich Diet
Dietary counseling + material promoting strength training an aerobic activity + a calcium intake of 1,200 - 2,500 mg/day. 6 month intervention.
- OTHER
-
Exercise + Fruit & Vegetable, Low Fat + Calcium Diet
1,200 - 2,500 Calcium intake per day. 6 month intervention period.
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH - lead OTHER
Principal Investigators
-
Edward G. Shaw, MD · Wake Forest University Health Sciences
-
Wendy Demark-Wahnefried, PhD · Duke Cancer Institute
-
Roger T. Anderson, PhD · Wake Forest University Health Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-09-30
- Primary Completion
- 2004-01-31
- Completion
- 2005-01-31
Countries
- United States
Study Locations
More Related Trials
-
Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers
NCT02087592 ·Status: COMPLETED ·Phase: NA
-
MBC Physical Activity Study
NCT06500858 ·Status: COMPLETED ·Phase: NA
-
Acute Exercise Cardioprotection From Doxorubicin
NCT02006979 ·Status: COMPLETED ·Phase: PHASE1
-
Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival
NCT02364557 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Diet and Exercise or Normal Care in Overweight or Obese Women Who Have Undergone Treatment for Stage I, Stage II, or Stage III Breast Cancer
NCT00689975 ·Status: COMPLETED ·Phase: NA
-
Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer
NCT00019643 ·Status: TERMINATED
-
Energy Balance and Breast Cancer Aspects-II
NCT02240836 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45
NCT00914043 ·Status: WITHDRAWN
-
Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer
NCT00925652 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
NCT03939481 ·Status: ACTIVE_NOT_RECRUITING
-
DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer
NCT00972023 ·Status: TERMINATED ·Phase: PHASE1
-
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
NCT02003209 ·Status: COMPLETED ·Phase: PHASE3
-
Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery
NCT00769470 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.
NCT03027063 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer
NCT00093795 ·Status: COMPLETED ·Phase: PHASE3
-
Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast Cancer
NCT00079170 ·Status: COMPLETED ·Phase: NA
-
Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer
NCT04352777 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolic Parameters and Quality of Life in Women on Neo-/Adjuvant Therapy for Breast Cancer
NCT07044791 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer
NCT00645866 ·Status: COMPLETED ·Phase: PHASE2
-
Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
NCT00005800 ·Status: COMPLETED ·Phase: PHASE2
-
Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE Trial
NCT04667481 ·Status: COMPLETED ·Phase: NA
-
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
NCT06395506 ·Status: RECRUITING ·Phase: NA
-
Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy
NCT06190600 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
NCT01275677 ·Status: COMPLETED ·Phase: PHASE3
-
Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer
NCT01334021 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2